Pages that link to "Q28207649"

The following pages link to Tianeptine: a review of its use in depressive disorders (Q28207649):

Displaying 44 items.

• Interventions to facilitate return to work in adults with adjustment disorders (Q24202277) (← links)
• The neurobiological properties of tianeptine (Stablon): from monoamine hypothesis to glutamatergic modulation (Q24613593) (← links)
• Evident exception in clinical practice not sufficient to break traditional hypothesis (Q25257328) (← links)
• (Q28175519) (redirect page) (← links)
• Neurobiological and clinical effects of the antidepressant tianeptine (Q28260673) (← links)
• Tianeptine vs amitriptyline for the treatment of irritable bowel syndrome with diarrhea: a multicenter, open-label, non-inferiority, randomized controlled study (Q28268467) (← links)
• Antidepressants and the Placebo Effect (Q28468667) (← links)
• (Q29393719) (redirect page) (← links)
• Chronic antidepressant treatment impairs the acquisition of fear extinction (Q30437449) (← links)
• Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine (Q30531104) (← links)
• The antidepressant tianeptine persistently modulates glutamate receptor currents of the hippocampal CA3 commissural associational synapse in chronically stressed rats. (Q34528009) (← links)
• Recent developments in the psychobiology and pharmacotherapy of depression: optimising existing treatments and novel approaches for the future (Q35040802) (← links)
• Treatment of the metabolic disturbances caused by antipsychotic drugs: focus on potential drug interactions (Q35625342) (← links)
• Trends in the development of new antidepressants. Is there a light at the end of the tunnel? (Q35743638) (← links)
• Structural plasticity and tianeptine: cellular and molecular targets (Q35791915) (← links)
• Autism spectrum disorders: emerging pharmacotherapy (Q36219642) (← links)
• Tianeptine: an antidepressant with memory-protective properties (Q37239732) (← links)
• Harm Reduction From Below: On Sharing and Caring in Drug Use. (Q37303683) (← links)
• New approaches to the pharmacological management of major depressive disorder (Q37709574) (← links)
• Safety of tianeptine use in patients with epilepsy (Q38439227) (← links)
• Acute Toxicity From Intravenous Use of the Tricyclic Antidepressant Tianeptine (Q38679364) (← links)
• Serotonin modulates the cytokine network in the lung: involvement of prostaglandin E2. (Q40084084) (← links)
• Tianeptine interferes with microtubule organization and hormone secretion of pheochromocytoma cells (Q42670989) (← links)
• Tianeptine influence on plasmatic catecholamine levels and anxiety index in rats under variable chronic stress after early maternal separation (Q43239863) (← links)
• Tianeptine and fluoxetine in major depression: a 6-week randomised double-blind study (Q44197182) (← links)
• Chronic treatment with the antidepressant tianeptine attenuates lipopolysaccharide-induced Fos expression in the rat paraventricular nucleus and HPA axis activation (Q44225482) (← links)
• The effects of paroxetine and tianeptine on peripheral biochemical markers in major depression. (Q44262055) (← links)
• Tianeptine: a novel strategy of psychopharmacological treatment of children with autistic disorder (Q44511468) (← links)
• Tianeptine combination for partial or non-response to selective serotonin re-uptake inhibitor monotherapy (Q44519573) (← links)
• Prenatal stress in rats predicts immobility behavior in the forced swim test. Effects of a chronic treatment with tianeptine (Q44616110) (← links)
• Effect of acute and chronic tianeptine on the action of classical antiepileptics in the mouse maximal electroshock model (Q44699076) (← links)
• Synaptic plasticity and tianeptine: structural regulation. (Q44920844) (← links)
• Paroxetine augmentation to tianeptine treatment causes exacerbation of depressive symptoms: presentation of two cases (Q47290988) (← links)
• Pharmacokinetic study of tianeptine and its active metabolite MC5 in rats following different routes of administration using a novel liquid chromatography tandem mass spectrometry analytical method (Q48137347) (← links)
• Highly Enantioselective Ferrocenyl Palladacycle-Acetate Catalysed Arylation of Aldimines and Ketimines with Arylboroxines. (Q48145645) (← links)
• Differential effects of predator stress and the antidepressant tianeptine on physiological plasticity in the hippocampus and basolateral amygdala (Q48509722) (← links)
• The Use of Placebos in Clinical Trials and Clinical Practice (Q48686992) (← links)
• Inhibitory effect of tianeptine on catagen induction in alopecia areata-like lesions induced by ultrasonic wave stress in mice (Q50235606) (← links)
• Cognitive Behavioral Therapy for Insomnia Reduces Hypnotic Prescriptions. (Q52563212) (← links)
• Depressive Disorders: Major Depressive Disorder and Persistent Depressive Disorder (Q57703141) (← links)
• Hydrophobic Amines and Their Guanidine Analogues Modulate Activation and Desensitization of ASIC3 (Q64069586) (← links)
• Modulation of antidepressant-like activity of magnesium by serotonergic system (Q80188585) (← links)
• Update on Eluxadoline for the Treatment of Irritable Bowel Syndrome with Diarrhea: Patient Selection and Perspectives (Q92059760) (← links)
• Enantioselective C,P-Palladacycle-Catalyzed Arylation of Imines (Q97530875) (← links)